Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.05
-0.15 (-2.88%)
At close: Sep 1, 2026, 4:00 PM EDT
5.10
+0.05 (0.99%)
Pre-market: Sep 2, 2026, 7:05 AM EDT

Unicycive Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-35.22-26.56-36.73-30.54-18.06-10.02
Depreciation & Amortization
0.660.570.430.280.160.01
Other Amortization
-----0.49
Asset Writedown & Restructuring Costs
-----2.19
Stock-Based Compensation
5.142.642.351.771.051.11
Other Operating Activities
3.5-2.025.810.30.020.55
Change in Accounts Payable
1.43-2.510.791.281.271.24
Change in Other Net Operating Assets
-3.34-3.45-1.22-1.37-0.09-1.35
Operating Cash Flow
-27.84-31.32-28.58-18.28-15.65-5.77
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.02-0.07-0.01-0-0.03
Investment in Securities
-17.24-12.07----
Investing Cash Flow
-17.25-12.1-0.07-0.01-0-0.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----1.35
Total Debt Issued
-----1.35
Short-Term Debt Repaid
------1.36
Total Debt Repaid
------1.36
Net Debt Issued (Repaid)
------0.02
Issuance of Common Stock
69.0248.080.68-0.0122.39
Preferred Dividends Paid
---1.1---
Dividends Paid
---1.1---
Other Financing Activities
-2.07-1.61-4.5-2.65-0.48-
Financing Cash Flow
66.9546.4745.0927.54-0.4722.38

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
21.863.0616.449.25-16.1216.58

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-27.85-31.34-28.65-18.3-15.65-5.8
Free Cash Flow Growth
------
Free Cash Flow Margin
----2710.37%-1645.95%-
Free Cash Flow Per Share
-1.23-1.97-4.28-7.46-10.40-4.96
Levered Free Cash Flow
-12.72-22.92-12.171.57-9.26-4.6
Unlevered Free Cash Flow
-12.68-22.88-12.131.62-9.26-4.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.010.020.01-
Change in Working Capital
-1.92-5.95-0.43-0.091.18-0.11
SEC Filings: 10-K · 10-Q